InMed Pharmaceuticals registers 3.9M shares for resale

* InMed Pharmaceuticals (NASDAQ:INM [https://seekingalpha.com/symbol/INM]) has filed a prospectus for the resale of up to 3.90M common shares by a selling shareholder and its permitted transferees.
* The offering includes 1.95M shares from pre-funded warrants and 1.95M shares from preferred investment options, both issued under a private placement.
* InMed will not receive proceeds from the resale of shares but may receive up to $4.76M from the exercise of preferred investment options, and $195 from pre-funded warrants if exercised for cash.
* Source: SEC filing [https://seekingalpha.com/filing/10178576]

MORE ON INMED PHARMACEUTICALS

* InMed Pharmaceuticals announces $5M private placement [https://seekingalpha.com/news/4462147-inmed-pharmaceuticals-announces-5m-private-placement]
* Financial information for InMed Pharmaceuticals [https://seekingalpha.com/symbol/INM/income-statement]